Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. CytoTools AG
  6. Summary
    T5O   DE000A0KFRJ1

CYTOTOOLS AG

(T5O)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
07/22/2021 07/23/2021 07/26/2021 07/27/2021 07/28/2021 Date
13.95(c) 14.7(c) 14.5(c) 15.1(c) 15.2(c) Last
2 161 11 981 2 396 1 134 776 Volume
+1.09% +5.38% -1.36% +4.14% +0.66% Change
More quotes
Estimated financial data (e)
Sales 2021 0,10 M 0,12 M 0,12 M
Net income 2021 -0,50 M -0,59 M -0,59 M
Net cash position 2021 5,40 M 6,39 M 6,39 M
P/E ratio 2021 -127x
Yield 2021 -
Sales 2022 2,75 M 3,25 M 3,25 M
Net income 2022 0,50 M 0,59 M 0,59 M
Net cash position 2022 5,70 M 6,75 M 6,75 M
P/E ratio 2022 127x
Yield 2022 -
Capitalization 61,2 M 72,3 M 72,5 M
EV / Sales 2021 558x
EV / Sales 2022 20,2x
Nbr of Employees 10
Free-Float 52,1%
More Financials
Company
CytoTools AG is a Germany-based investment and holding company active in the biotechnology sector. The Company holds interests in research and development (R&D) companies DermaTools Biotech GmbH, which is active in the field of dermatology and urology, and CytoPharma GmbH, which is engaged in product development for cardiovascular diseases, cancer and other indications. CytoTools AG manages the patent portfolio and... 
More about the company
Ratings of CytoTools AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about CYTOTOOLS AG
07/26Lordstown Motors says hedge fund may buy up to $400 million of its stock
RE
07/26Lordstown Motors says hedge fund may buy up to $400 mln of its stock
RE
07/20CYTOTOOLS : postpones Annual General Meeting (132.6 KiB)
PU
07/01Cytotools Ag Reports Earnings Results for the Full Year Ended December 31, 20..
CI
06/30CYTOTOOLS : cures resolution of 2020 Annual General Meeting with proposed capita..
PU
06/29PRESS RELEASE : CytoTools cures resolution of 2020 Annual General Meeting with p..
DJ
06/29CYTOTOOLS : cures resolution of 2020 Annual General Meeting with proposed capita..
EQ
06/23CYTOTOOLS : Treatment numbers in India slightly above previous quarter (102.9 Ki..
PU
06/21CYTOTOOLS Q1 TRADING UPDATE : Treatment numbers in India slightly above previous..
EQ
06/21PRESS RELEASE : CytoTools Q1 Trading Update: Treatment numbers in India slightly..
DJ
06/21CytoTools AG's Licensing Partner Centaur Pharmaceuticals Inc. Receives Tentat..
CI
04/26CYTOTOOLS : Joins Activoris Medizintechnik To Develop Inhalation Therapy
MT
04/26PRESS RELEASE : CytoTools signs collaboration agreement to develop inhalation th..
DJ
04/26CYTOTOOLS : signs collaboration agreement to develop inhalation therapy for vira..
EQ
04/26CytoTools Signs Collaboration Agreement to Develop Inhalation Therapy for Vir..
CI
More news
News in other languages on CYTOTOOLS AG
07/26CYTOTOOLS : Einladung/Tagesordnung
07/23CYTOTOOLS : Informationen gem. ž 125 AktG in Form der Tabelle 3 der EU-DVO
07/20CYTOTOOLS : verschiebt Hauptversammlung (137,0 KiB)
07/20DGAP-NEWS : CytoTools AG: Verschiebung Hauptversammlung
07/20CYTOTOOLS AG : Verschiebung Hauptversammlung
More news
Chart CYTOTOOLS AG
Duration : Period :
CytoTools AG Technical Analysis Chart | T5O | DE000A0KFRJ1 | MarketScreener
Technical analysis trends CYTOTOOLS AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 15,20 €
Average target price 38,45 €
Spread / Average Target 153%
EPS Revisions
Managers and Directors
Mark-Andre Freyberg Chief Executive Officer
Manfred May Chairman-Supervisory Board
Matthias Hoffmann Member-Supervisory Board
Bernhard Seehaus Member-Supervisory Board
Heiner Hoppmann Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
CYTOTOOLS AG-6.75%72
MODERNA, INC.214.44%131 902
LONZA GROUP AG20.01%55 520
IQVIA HOLDINGS INC.35.73%46 608
CELLTRION, INC.-27.16%31 131
SEAGEN INC.-17.54%26 209